← Back to Search

Eye-Tracking for Word Learning in Deaf Children

N/A
Recruiting
Led By Amy Lieberman, PhD
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Deaf children ages 18-60 months born severely to profoundly deaf
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 seconds following experimenter prompt
Awards & highlights

Study Summary

This trial explores if deaf children learning sign language assume each object has one word ("mutual exclusivity"). It also explores if those learning both sign & spoken language demonstrate the same behavior.

Who is the study for?
This trial is for deaf children aged 18-60 months who were born with severe to profound hearing loss. It's suitable for those who use American Sign Language (ASL) and have normal or corrected-to-normal vision, regardless of whether their parents are deaf or hearing.Check my eligibility
What is being tested?
The study investigates how deaf children learn words using a principle called mutual exclusivity - the idea that each object has only one name. Researchers will see if this applies to kids learning ASL and those learning both ASL and spoken language through eye-tracking and behavior observation.See study design
What are the potential side effects?
Since this study involves observational methods like eye-tracking rather than medical interventions, there are no direct side effects associated with it. However, participation may involve typical discomforts from wearing eye-tracking equipment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child, aged 18-60 months, was born with severe to profound deafness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 seconds following experimenter prompt
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 seconds following experimenter prompt for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Selected object

Trial Design

1Treatment groups
Experimental Treatment
Group I: Referential cues to objectExperimental Treatment1 Intervention
Each object pair that is presented to the child is accompanied by 1) gaze only (3 trials); 2) novel label only (3 trials); or 3) conflicting gaze and novel label (3 trials)

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor
114 Previous Clinical Trials
12,250 Total Patients Enrolled
1 Trials studying Hearing Loss
220 Patients Enrolled for Hearing Loss
Amy Lieberman, PhDPrincipal InvestigatorBoston University

Media Library

Referential cues to object Clinical Trial Eligibility Overview. Trial Name: NCT05993832 — N/A
Hearing Loss Research Study Groups: Referential cues to object
Hearing Loss Clinical Trial 2023: Referential cues to object Highlights & Side Effects. Trial Name: NCT05993832 — N/A
Referential cues to object 2023 Treatment Timeline for Medical Study. Trial Name: NCT05993832 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any qualifying criteria for entering this research project?

"Qualified participants must have a history of hearing impairment and be between 1.5 years old to 5 years old. At present, the study is looking for 40 individuals that satisfy these criteria."

Answered by AI

Is access to this experiment currently available for participants?

"Data on clinicaltrials.gov shows us that this trial is actively seeking candidates, having been published and last modified on the 8th of July 2023."

Answered by AI

Is the age limit of 65+ applicable for enrollment in this experimental trial?

"This medical trial is looking for participants between the ages of 18 months and 60 months."

Answered by AI

What is the cumulative number of participants who have registered for this experiment?

"Correct. Data hosted on clinicaltrials.gov affirms that this experiment, which was first published on the 8th of July 2023, is actively seeking participants. Around 40 volunteers need to be enrolled from 1 medical centre."

Answered by AI
~27 spots leftby May 2026